Status: Recruiting
Study on Prostate Salvage Using High-dose-rate Brachytherapy
A prospective, observational, multicenter study analyzing salvage treatment for prostate cancer-diagnosed via next-generation imaging (choline positron emission tomography (PET)/prostate-specific membrane antigen (PSMA) PET and magnetic resonance imaging (MRI)) and positive biopsy-using two fractions of high-dose-rate (HDR) brachytherapy.
Participants needed: 63
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Instituto de Investigación en Oncología Radioterápica - Fundación Española de Oncología RadioterápicUpdated: Oct 9, 2026Locations: 10Duration: 4 Years
Eligibility criteria
Age over 18 years. [+3]
Metastatic disease. [+1]